Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma

DOI PDF 被引用文献2件
  • Niklas Gebauer
    Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany;
  • Hanno M. Witte
    Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany;
  • Hartmut Merz
    Hämatopathologie Lübeck, Reference Centre for Lymph Node Pathology and Hematopathology, Lübeck, Germany;
  • Ilske Oschlies
    Department of Pathology, Hematopathology Section, Reference Centre for Lymph Node Pathology and Hematopathology,
  • Wolfram Klapper
    Department of Pathology, Hematopathology Section, Reference Centre for Lymph Node Pathology and Hematopathology,
  • Almuth Caliebe
    Institute of Human Genetics, University Hospital of Schleswig-Holstein, Kiel, Germany; and
  • Lars Tharun
    Department of Pathology, University Hospital of Schleswig-Holstein, Lübeck, Germany
  • Malte Spielmann
    Institute of Human Genetics, University Hospital of Schleswig-Holstein, Kiel, Germany; and
  • Nikolas von Bubnoff
    Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany;
  • Alfred C. Feller
    Hämatopathologie Lübeck, Reference Centre for Lymph Node Pathology and Hematopathology, Lübeck, Germany;
  • Eva M. Murga Penas
    Institute of Human Genetics, University Hospital of Schleswig-Holstein, Kiel, Germany; and

抄録

<jats:title>Abstract</jats:title> <jats:p>The recent characterization of a group of non-MYC rearranged aggressive B-cell lymphomas, resembling Burkitt lymphoma (BL), characteristically harboring a telomeric 11q loss or combined 11q proximal gains/loss pattern has led to the introduction of the provisional entity of Burkitt-like lymphoma with 11q aberration (BLL-11q). Prompted by the discovery of a telomeric 11q loss in an HIV+ high-grade B-cell lymphoma patient, we investigated an extended cohort of aggressive B-cell lymphomas, enriched for cases with histopathological features intermediate between DLBCL and BL, including double- and triple-hit lymphomas (n = 47), for 11q loss/combined 11q proximal gains/loss pattern by fluorescence in situ hybridization. We provide first evidence that 11q aberrations can be found in both BLL in the context of an underlying HIV infection as well as in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. We therefore propose that the clinicopathological spectrum of malignancies carrying this aberration may be broader than previously assumed.</jats:p>

収録刊行物

  • Blood Advances

    Blood Advances 5 (23), 5220-5225, 2021-12-07

    American Society of Hematology

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ